eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Document ID:
DEA-2009-0002-0001
Document Type:
Proposed Rule
Agency:
Drug Enforcement Administration
Topics:
Administrative Practices and Procedures, Drug Traffic Control, Narcotics, Prescription Drugs
CFR Citation:
21 CFR Part 1308
View Document:
Details Information
Received Date:
February 17 2009, at 02:31 PM Eastern Standard Time
Start-End Page:
7386 - 7388
Comment Start Date:
February 17 2009, at 12:00 AM Eastern Standard Time
Comment Due Date:
March 19 2009, at 11:59 PM Eastern Standard Time
Comments
Total:
3
Chadwick Bucur Comment on DEA-319
Submitter:
Bucur, Chadwick
Posted:
02/19/2009
ID:
DEA-2009-0002-0004
Comment Period Closed
Mar 19,2009 11:59 PM ET
John Coleman Comment on DEA-319
Submitter:
Coleman, PhD, John
Posted:
03/23/2009
ID:
DEA-2009-0002-0006
Comment Period Closed
Mar 19,2009 11:59 PM ET
Ryan York comment on DEA-319
Submitter:
York, Ryan
Posted:
03/10/2009
ID:
DEA-2009-0002-0005
Comment Period Closed
Mar 19,2009 11:59 PM ET
Related Documents
More
Total:
32
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids Into Schedule I
Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
Establishment of Drug Codes for 26 Substances
Schedules of Controlled Substances: Placement of Lorcaserin into Schedule IV
Schedules of Controlled Substances: Extension of Temporary Placement of Methylone Into Schedule I
Schedules of Controlled Substances: Placement of Methylone into Schedule I
Schedules of Controlled Substances: Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act
Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V
Schedules of Controlled Substances: Placement of Carisoprodol Into Schedule IV
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Schedules of Controlled Substances: Placement of Ezogabine into Schedule V
Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cathinones Into Schedule I
Establishment of a New Drug Code for Marihuana Extract
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I; Correction
Schedules of Controlled Substances: Placement of 5-Methoxy-N,N-Dimethyltryptamine into Schedule I of Controlled Substances Act
Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids into Schedule I
Listing of Approved Drug Products Containing Dronabinol in Schedule III
Schedules of Controlled Substances: Placement of Propofol into Schedule IV
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Schedules of Controlled Substances: Placement of 2,5-Dimethoxy-4-(n)-propylthiophenethylamine and N-Benzylpiperazine into Schedule I of Controlled Substances Act; Correction
Correction of Code of Federal Regulations: Removal of Temporary Listing of Benzylfentanyl and Thenylfentanyl as Controlled Substances
Control of Immediate Precursors Used in Illicit Manufacture of Fentanyl as Schedule II Controlled Substance
Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira
Schedules of Controlled Substances: Placement of Carisoprodol into Schedule IV; Announcement of Hearing
Schedules of Controlled Substances; Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhalers Manufactured by Classic Pharmaceuticals, LLC
Schedules of Controlled Substances: Placement of Fospropofol into Schedule IV
Schedules of Controlled Substances: Placement of Lacosamide into Schedule V
Schedules of Controlled Substances: Placement of Tapentadol into Schedule II
Details Information
Comments
Submitter: Bucur, Chadwick Posted: 02/19/2009 ID: DEA-2009-0002-0004
Mar 19,2009 11:59 PM ET
Submitter: Coleman, PhD, John Posted: 03/23/2009 ID: DEA-2009-0002-0006
Mar 19,2009 11:59 PM ET
Submitter: York, Ryan Posted: 03/10/2009 ID: DEA-2009-0002-0005
Mar 19,2009 11:59 PM ET
Related Documents
More